Global Atrial Septal Defect Market Report 2024

Atrial Septal Defect Global Market Report 2024 – By Treatment Procedure (Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy), By Diagnosis (Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry), By Product Type (Medical Devices, Pharmaceutical Products), By Age Group (Pediatric, Adult), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Atrial Septal Defect Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : August 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Atrial Septal Defect Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Atrial Septal Defect Market Definition

An atrial septal defect (ASD) refers to a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, which can lead to increased blood flow to the lungs and over time cause complications like pulmonary hypertension and heart failure.

The main treatment procedures for arterial septal defect are surgical closure, transcatheter closer, hybrid procedures, and medication therapy. Surgical closure refers to a procedure where an abnormal opening or defect in the body, such as in the heart, is repaired or sealed through surgical intervention. Diagnostic methods encompass chest x-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry, facilitated by medical devices and pharmaceutical products. These diagnostics serve pediatric and adult patients across various end-user settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.

Atrial Septal Defect Market Segmentation

The atrial septal defect market covered in this report is segmented –

1) By Treatment Procedure: Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy

2) By Diagnosis: Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry

3) By Product Type: Medical Devices, Pharmaceutical Products

4) By Age Group: Pediatric, Adult

5) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users

Global Atrial Septal Defect Market Size 2023 to 2028: Graph

Atrial Septal Defect Market Size 2024 And Growth Rate

The atrial septal defect market size has grown strongly in recent years. It will grow from $3.85 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities.

Atrial Septal Defect Market Growth Forecast

The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early.

Atrial Septal Defect Market Driver: Growing Prevalence of Congenital Heart Defects (CHD) Drive Atrial Septal Defect Market Expansion

The prevalence of congenital heart defects (CHD) is expected to propel the growth of the atrial septal defect market going forward. Congenital heart defects refer to structural abnormalities in the heart present at birth. The increasing prevalence of congenital heart defects refers to the growing number of individuals diagnosed with structural heart abnormalities present from birth. Atrial septal defect treatment helps manage congenital heart defects by correcting abnormal blood flow between the heart's chambers, improving overall heart function, and reducing associated complications. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based national agency, in Australia, approximately 65,000 children and adults are living with congenital heart disease. In the 2020–21 period, there were about 5,900 hospitalizations where congenital heart disease was the primary diagnosis, accounting for 79 deaths in infants under one year old, representing 7.8% of all infant deaths. Therefore, the prevalence of congenital heart defects will drive the atrial septal defect market.

Global Atrial Septal Defect Market Major Players

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC

Global Atrial Septal Defect Market Trend: Advancements In Occluders For Arterial Septal Defect Treatment

Major companies operating in the arterial septal defect market are developing advanced devices and seeking approval to increase their availability and uses. Device approval refers to obtaining official authorization or certification for a device, typically from a regulatory body or relevant authority, before it can be legally manufactured, sold, or used in a specific market or for a particular purpose. For instance, in March 2024, Occlutech GmbH, a Sweden-based specialist provider of minimally invasive cardiac devices, announced that the United States Food and Drug Administration (FDA) had approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This approval marks a significant milestone for the company, which has been working to advance healthcare globally. The Occlutech ASD Occluder is designed to be a lifelong solution for patients with echocardiography-confirmed defects. It is a self-expanding nitinol device that includes two flexible discs attached to both sides of the patient's atrial septum using the Occlutech Pistol Pusher. With this approval, Occlutech will begin commercialization in the US through an exclusive partnership with B. Braun Interventional Systems.

Atrial Septal Defect Market Merger And Acquisition: Expansion Of Boston Scientific's Product Portfolio Through Acquisition Of Baylis Medical

In February 2022, Boston Scientific Corporation, a US-based medical products company, acquired Baylis Medical Company Inc. for $1.75 billion. The acquisition expands Boston Scientific's electrophysiology and structural heart product portfolios to include Baylis Medical's transseptal platforms and guidewires, sheaths, and dilators for left heart access. Baylis Medical Company Inc. is a Canada-based medical company that manufactures the VersaCross RF Wire, designed to create atrial septal defects in the heart.

Regional Insights For The Global Atrial Septal Defect Market

North America was the largest region in the atrial septal defect market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atrial septal defect market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The arterial septal defect research report is one of a series of new reports from The Business Research Company that provides arterial septal defect market statistics, including the arterial septal defect industry's global market size, regional shares, competitors with an arterial septal defect market share, detailed arterial septal defect market segments, market trends and opportunities, and any further data you may need to thrive in the arterial septal defect industry. This arterial septal defect market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Atrial Septal Defect Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $4.14 billion
Revenue Forecast In 2033 $5.6 billion
Growth Rate CAGR of 7.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment Procedure: Surgical Closure; Transcatheter Closure; Hybrid Procedures; Medication Therapy
2) By Diagnosis: Chest X-Ray; Electrocardiogram; Cardiac Catheterization; Transesophageal Echocardiography; Pulse Oximetry
3) By Product Type: Medical Devices; Pharmaceutical Products
4) By Age Group: Pediatric; Adult
5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Atrial Septal Defect Market Characteristics

    3. Atrial Septal Defect Market Trends And Strategies

    4. Atrial Septal Defect Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Atrial Septal Defect Market Size and Growth

    5.1. Global Atrial Septal Defect Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Atrial Septal Defect Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Atrial Septal Defect Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Atrial Septal Defect Market Segmentation

    6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Surgical Closure

    Transcatheter Closure

    Hybrid Procedures

    Medication Therapy

    6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Chest X-Ray

    Electrocardiogram

    Cardiac Catheterization

    Transesophageal Echocardiography

    Pulse Oximetry

    6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medical Devices

    Pharmaceutical Products

    6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pediatric

    Adult

    6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Ambulatory Surgical Centers

    Cardiac Clinics

    Other End-Users

    7. Atrial Septal Defect Market Regional And Country Analysis

    7.1. Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Atrial Septal Defect Market

    8.1. Asia-Pacific Atrial Septal Defect Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Atrial Septal Defect Market

    9.1. China Atrial Septal Defect Market Overview

    9.2. China Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Atrial Septal Defect Market

    10.1. India Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Atrial Septal Defect Market

    11.1. Japan Atrial Septal Defect Market Overview

    11.2. Japan Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Atrial Septal Defect Market

    12.1. Australia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Atrial Septal Defect Market

    13.1. Indonesia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Atrial Septal Defect Market

    14.1. South Korea Atrial Septal Defect Market Overview

    14.2. South Korea Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Atrial Septal Defect Market

    15.1. Western Europe Atrial Septal Defect Market Overview

    15.2. Western Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Atrial Septal Defect Market

    16.1. UK Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Atrial Septal Defect Market

    17.1. Germany Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Atrial Septal Defect Market

    18.1. France Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Atrial Septal Defect Market

    19.1. Italy Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Atrial Septal Defect Market

    20.1. Spain Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Atrial Septal Defect Market

    21.1. Eastern Europe Atrial Septal Defect Market Overview

    21.2. Eastern Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Atrial Septal Defect Market

    22.1. Russia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Atrial Septal Defect Market

    23.1. North America Atrial Septal Defect Market Overview

    23.2. North America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Atrial Septal Defect Market

    24.1. USA Atrial Septal Defect Market Overview

    24.2. USA Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Atrial Septal Defect Market

    25.1. Canada Atrial Septal Defect Market Overview

    25.2. Canada Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Atrial Septal Defect Market

    26.1. South America Atrial Septal Defect Market Overview

    26.2. South America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Atrial Septal Defect Market

    27.1. Brazil Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Atrial Septal Defect Market

    28.1. Middle East Atrial Septal Defect Market Overview

    28.2. Middle East Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Atrial Septal Defect Market

    29.1. Africa Atrial Septal Defect Market Overview

    29.2. Africa Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Atrial Septal Defect Market Competitive Landscape And Company Profiles

    30.1. Atrial Septal Defect Market Competitive Landscape

    30.2. Atrial Septal Defect Market Company Profiles

    30.2.1. Abbott Laboratories

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Medtronic plc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Siemens Healthineers

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Boston Scientific Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Philips Healthcare

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Atrial Septal Defect Market Other Major And Innovative Companies

    31.1. Edwards Lifesciences Corporation

    31.2. W. L. Gore & Associates Inc.

    31.3. St. Jude Medical LLC

    31.4. Cook Medical

    31.5. Lepu Medical Technology Co. Ltd.

    31.6. MicroPort Scientific Corporation

    31.7. Lifetech Scientific Corporation

    31.8. Venus Medtech Hangzhou Inc

    31.9. Occlutech Holding AG

    31.10. Coherex Medical

    31.11. Osypka AG

    31.12. Arjo AB

    31.13. Heart Medical Europe BV

    31.14. AtriCure Inc.

    31.15. Asklepion Pharmaceuticals LLC

    32. Global Atrial Septal Defect Market Competitive Benchmarking

    33. Global Atrial Septal Defect Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Atrial Septal Defect Market

    35. Atrial Septal Defect Market Future Outlook and Potential Analysis

    35.1 Atrial Septal Defect Market In 2028 - Countries Offering Most New Opportunities

    35.2 Atrial Septal Defect Market In 2028 - Segments Offering Most New Opportunities

    35.3 Atrial Septal Defect Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Abbott Laboratories Financial Performance
  • Table 77: Medtronic plc Financial Performance
  • Table 78: Siemens Healthineers Financial Performance
  • Table 79: Boston Scientific Corporation Financial Performance
  • Table 80: Philips Healthcare Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Abbott Laboratories Financial Performance
  • Figure 77: Medtronic plc Financial Performance
  • Figure 78: Siemens Healthineers Financial Performance
  • Figure 79: Boston Scientific Corporation Financial Performance
  • Figure 80: Philips Healthcare Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Atrial Septal Defect market?

An atrial septal defect (ASD) refers to a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, which can lead to increased blood flow to the lungs and over time cause complications like pulmonary hypertension and heart failure. For further insights on the Atrial Septal Defect market, request a sample here

How will the Atrial Septal Defect market drivers and restraints affect the Atrial Septal Defect market dynamics? What forces will shape the Atrial Septal Defect industry going forward?

The Atrial Septal Defect market major growth driver - Growing Prevalence of Congenital Heart Defects (CHD) Drive Atrial Septal Defect Market Expansion. For further insights on the Atrial Septal Defect market, request a sample here

What is the forecast market size or the forecast market value of the Atrial Septal Defect market?

The atrial septal defect market size has grown strongly in recent years. It will grow from $3.85 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities. The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early. For further insights on the Atrial Septal Defect market, request a sample here

How is the Atrial Septal Defect market segmented?

The Atrial Septal Defect market is segmented
1) By Treatment Procedure: Surgical Closure, Transcatheter Closure, Hybrid Procedures, Medication Therapy
2) By Diagnosis: Chest X-Ray, Electrocardiogram, Cardiac Catheterization, Transesophageal Echocardiography, Pulse Oximetry
3) By Product Type: Medical Devices, Pharmaceutical Products
4) By Age Group: Pediatric, Adult
5) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Other End-Users For further insights on the Atrial Septal Defect market,
request a sample here

Which region has the largest share of the Atrial Septal Defect market? What are the other regions covered in the report?

North America was the largest region in the atrial septal defect market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Atrial Septal Defect market, request a sample here.

Who are the major players in the Atrial Septal Defect market?

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC For further insights on the Atrial Septal Defect market, request a sample here.

What are the key trends in the Atrial Septal Defect market?

Major trend in the Atrial Septal Defect market - Advancements In Occluders For Arterial Septal Defect Treatment. For further insights on the Atrial Septal Defect market, request a sample here.

What are the major opportunities in the Atrial Septal Defect market? What are the strategies for the Atrial Septal Defect market?

For detailed insights on the major opportunities and strategies in the Atrial Septal Defect market, request a sample here.

How does the Atrial Septal Defect market relate to the overall economy and other similar markets?

For detailed insights on Atrial Septal Defect market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Atrial Septal Defect industry?

For detailed insights on the mergers and acquisitions in the Atrial Septal Defect industry, request a sample here.

What are the key dynamics influencing the Atrial Septal Defect market growth? SWOT analysis of the Atrial Septal Defect market.

For detailed insights on the key dynamics influencing the Atrial Septal Defect market growth and SWOT analysis of the Atrial Septal Defect industry, request a sample here.